- Home
- DBVT vs CGC Comparison
DBVT vs CGC Comparison
Compare DBVT & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- CGC
- Stock Information
- Founded
- DBVT 2002
- CGC N/A
- Country
- DBVT France
- CGC Canada
- Employees
- DBVT N/A
- CGC N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- CGC Pharmaceuticals and Biotechnology
- Sector
- DBVT Health Care
- CGC Health Care
- Exchange
- DBVT Nasdaq
- CGC Nasdaq
- Market Cap
- DBVT 464.0M
- CGC 427.4M
- IPO Year
- DBVT N/A
- CGC N/A
- Fundamental
- Price
- DBVT $15.55
- CGC $1.29
- Analyst Decision
- DBVT Buy
- CGC Hold
- Analyst Count
- DBVT 4
- CGC 1
- Target Price
- DBVT $14.81
- CGC N/A
- AVG Volume (30 Days)
- DBVT 203.8K
- CGC 23.2M
- Earning Date
- DBVT 10-28-2025
- CGC 11-07-2025
- Dividend Yield
- DBVT N/A
- CGC N/A
- EPS Growth
- DBVT N/A
- CGC N/A
- EPS
- DBVT N/A
- CGC N/A
- Revenue
- DBVT $3,800,000.00
- CGC $201,572,742.00
- Revenue This Year
- DBVT $1,743.46
- CGC $13.24
- Revenue Next Year
- DBVT $1,044.34
- CGC $3.68
- P/E Ratio
- DBVT N/A
- CGC N/A
- Revenue Growth
- DBVT N/A
- CGC N/A
- 52 Week Low
- DBVT $2.21
- CGC $0.77
- 52 Week High
- DBVT $18.00
- CGC $5.80
- Technical
- Relative Strength Index (RSI)
- DBVT 60.41
- CGC 44.52
- Support Level
- DBVT $14.85
- CGC $1.27
- Resistance Level
- DBVT $16.95
- CGC $1.42
- Average True Range (ATR)
- DBVT 1.14
- CGC 0.11
- MACD
- DBVT -0.18
- CGC -0.01
- Stochastic Oscillator
- DBVT 28.24
- CGC 4.17
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.